Gerstner, E. R., Emblem, K. E., Yen, Y., Dietrich, J., Jordan, J. T., Catana, C., . . . Batchelor, T. T. (2020). Vascular dysfunction promotes regional hypoxia after bevacizumab therapy in recurrent glioblastoma patients. Neurooncol Adv.
Chicago-stil citatGerstner, Elizabeth R., et al. "Vascular Dysfunction Promotes Regional Hypoxia After Bevacizumab Therapy in Recurrent Glioblastoma Patients." Neurooncol Adv 2020.
MLA-referensGerstner, Elizabeth R., et al. "Vascular Dysfunction Promotes Regional Hypoxia After Bevacizumab Therapy in Recurrent Glioblastoma Patients." Neurooncol Adv 2020.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.